Lake Street Capital Lowers Lakeland Industries (NASDAQ:LAKE) Price Target to $13.00

Lakeland Industries (NASDAQ:LAKE) had its price target dropped by stock analysts at Lake Street Capital from $16.00 to $13.00 in a research note issued to investors on Friday, Marketbeat.com reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Lake Street Capital’s target price points to a potential upside of 16.07% from the company’s previous close.

LAKE has been the topic of a number of other reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Lakeland Industries in a report on Thursday, January 22nd. Zacks Research upgraded shares of Lakeland Industries from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Finally, DA Davidson reduced their target price on shares of Lakeland Industries from $14.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday, April 8th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Lakeland Industries presently has a consensus rating of “Hold” and an average price target of $14.00.

Lakeland Industries Price Performance

Lakeland Industries stock opened at $11.20 on Friday. The firm has a market cap of $109.83 million, a PE ratio of -4.34 and a beta of 1.34. Lakeland Industries has a 52-week low of $7.15 and a 52-week high of $20.50. The company has a quick ratio of 1.48, a current ratio of 3.83 and a debt-to-equity ratio of 0.28. The company’s 50 day moving average is $8.94 and its two-hundred day moving average is $11.32.

Lakeland Industries (NASDAQ:LAKE) last released its earnings results on Thursday, April 16th. The medical instruments supplier reported ($0.61) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.42). The business had revenue of $45.82 million for the quarter, compared to analyst estimates of $49.67 million. Lakeland Industries had a negative return on equity of 9.36% and a negative net margin of 13.14%. On average, research analysts expect that Lakeland Industries will post 0.48 EPS for the current fiscal year.

Institutional Investors Weigh In On Lakeland Industries

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Invesco Ltd. raised its holdings in shares of Lakeland Industries by 30.8% in the 4th quarter. Invesco Ltd. now owns 20,114 shares of the medical instruments supplier’s stock valued at $178,000 after purchasing an additional 4,733 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Lakeland Industries in the 4th quarter valued at $130,000. Private Capital Management LLC raised its holdings in shares of Lakeland Industries by 2.8% in the 4th quarter. Private Capital Management LLC now owns 1,202,433 shares of the medical instruments supplier’s stock valued at $10,630,000 after purchasing an additional 32,945 shares in the last quarter. Expect Equity LLC raised its holdings in shares of Lakeland Industries by 6.9% in the 4th quarter. Expect Equity LLC now owns 166,061 shares of the medical instruments supplier’s stock valued at $1,468,000 after purchasing an additional 10,705 shares in the last quarter. Finally, Jain Global LLC acquired a new stake in shares of Lakeland Industries in the 4th quarter valued at $202,000. 71.69% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Lakeland Industries

Here are the key news stories impacting Lakeland Industries this week:

• Positive Sentiment: Management gave forward targets and strategic items that support a recovery thesis — management outlined high single‑digit fiscal 2027 revenue growth and a plan to grow services to $30M by FY2028, aiming for improved cash flow and steadier margins. Article Title
• Positive Sentiment: Company completed a ~$14M cash divestiture (HPFR and HiViz lines), reported FY26 net sales growth (15% year) and received NFPA 1970 certifications for full portfolio — actions that improve liquidity, product sellability and near‑term order potential. Article Title
• Positive Sentiment: An analyst from Lake Street Capital maintains a “buy” rating (but lowered the target to $13), providing an institutional buying signal and a modest upside reference for investors. Article Title
• Neutral Sentiment: New product activity: Lakeland Fire + Safety introduced a structural firefighting boot, which may help niche product momentum but is unlikely to move near‑term revenue materially. Article Title
• Negative Sentiment: Q4 results missed expectations: LAKE reported a wider loss (EPS -$0.61 vs. -$0.19 est.) and revenue below consensus, with margins and EBITDA pressured by tariffs, raw materials and freight — results and management comments disappointed some investors and analysts. Article Title
• Negative Sentiment: Multiple law firms have filed or are soliciting lead‑plaintiff candidates in a securities class action covering Dec 1, 2023–Dec 9, 2025, and set an April 24 deadline to join — increasing legal overhang and potential liability/expense risk. Article Title

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.